High-novelty-preference rats are predisposed to compulsive cocaine self-administration.
Identifieur interne : 001768 ( Main/Corpus ); précédent : 001767; suivant : 001769High-novelty-preference rats are predisposed to compulsive cocaine self-administration.
Auteurs : David Belin ; Nadège Berson ; Eric Balado ; Pier Vincenzo Piazza ; Véronique Deroche-GamonetSource :
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [ 1740-634X ] ; 2011.
English descriptors
- KwdEn :
- Anesthetics, Local (administration & dosage), Anesthetics, Local (pharmacology), Animals (MeSH), Behavior, Animal (drug effects), Cocaine (administration & dosage), Cocaine (pharmacology), Compulsive Behavior (physiopathology), Compulsive Behavior (psychology), Conditioning, Operant (drug effects), Disease Models, Animal (MeSH), Exploratory Behavior (drug effects), Exploratory Behavior (physiology), Male (MeSH), Motor Activity (drug effects), Motor Activity (physiology), Rats (MeSH), Rats, Sprague-Dawley (MeSH), Regression Analysis (MeSH), Self Administration (MeSH), Statistics, Nonparametric (MeSH).
- MESH :
- chemical , administration & dosage : Anesthetics, Local, Cocaine.
- chemical , pharmacology : Anesthetics, Local, Cocaine.
- drug effects : Behavior, Animal, Conditioning, Operant, Exploratory Behavior, Motor Activity.
- physiology : Exploratory Behavior, Motor Activity.
- physiopathology : Compulsive Behavior.
- psychology : Compulsive Behavior.
- Animals, Disease Models, Animal, Male, Rats, Rats, Sprague-Dawley, Regression Analysis, Self Administration, Statistics, Nonparametric.
Abstract
Sensation/novelty-seeking is amongst the best markers of cocaine addiction in humans. However, its implication in the vulnerability to cocaine addiction is still a matter of debate, as it is unclear whether this trait precedes or follows the development of addiction. Sensation/novelty-seeking trait has been identified in rats on the basis of either novelty-induced locomotor activity (high-responder (HR) trait) or novelty-induced place preference (high-novelty-preference trait (HNP)). HR and HNP traits have been associated with differential sensitivity to psychostimulants. However, it has recently been demonstrated that HR rats do not develop compulsive cocaine self-administration (SA) after protracted exposure to the drug, thereby suggesting that at least one dimension of sensation/novelty seeking in the rat is dissociable from the vulnerability to switch from controlled to compulsive cocaine SA. We therefore investigated whether HNP, as measured as the propensity to choose a new environment in a free choice procedure, as opposed to novelty-induced locomotor activity, predicts the vulnerability to, and the severity of, addiction-like behavior for cocaine. For this, we identified HR/LR rats and HNP/LNP rats before any exposure to cocaine. After 60 days of cocaine SA, each rat was given an addiction score based on three addiction-like behaviors (persistence of responding when the drug is signaled as not available, high breakpoint under progressive ratio schedule and resistance to punishment) that resemble the clinical features of drug addiction, namely inability to refrain from drug seeking, high motivation for the drug and compulsive drug use despite adverse consequences. We show that, as opposed to HR rats, HNP rats represent a sub-population predisposed to compulsive cocaine intake, displaying higher addiction scores than LNP rats. This study thereby provides new insights into the factors predisposing to cocaine addiction, supporting the hypothesis that addiction is sustained by two vulnerable phenotypes: a 'drug use prone' phenotype such as HR which brings an individual to develop drug use and an 'addiction prone' phenotype, such as HNP, which facilitates the shift from sustained to compulsive drug intake and addiction.
DOI: 10.1038/npp.2010.188
PubMed: 20980989
PubMed Central: PMC3055686
Links to Exploration step
pubmed:20980989Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">High-novelty-preference rats are predisposed to compulsive cocaine self-administration.</title>
<author><name sortKey="Belin, David" sort="Belin, David" uniqKey="Belin D" first="David" last="Belin">David Belin</name>
<affiliation><nlm:affiliation>University of Bordeaux, Bordeaux Cedex, France. david.belin@inserm.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berson, Nadege" sort="Berson, Nadege" uniqKey="Berson N" first="Nadège" last="Berson">Nadège Berson</name>
</author>
<author><name sortKey="Balado, Eric" sort="Balado, Eric" uniqKey="Balado E" first="Eric" last="Balado">Eric Balado</name>
</author>
<author><name sortKey="Piazza, Pier Vincenzo" sort="Piazza, Pier Vincenzo" uniqKey="Piazza P" first="Pier Vincenzo" last="Piazza">Pier Vincenzo Piazza</name>
</author>
<author><name sortKey="Deroche Gamonet, Veronique" sort="Deroche Gamonet, Veronique" uniqKey="Deroche Gamonet V" first="Véronique" last="Deroche-Gamonet">Véronique Deroche-Gamonet</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20980989</idno>
<idno type="pmid">20980989</idno>
<idno type="doi">10.1038/npp.2010.188</idno>
<idno type="pmc">PMC3055686</idno>
<idno type="wicri:Area/Main/Corpus">001768</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001768</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">High-novelty-preference rats are predisposed to compulsive cocaine self-administration.</title>
<author><name sortKey="Belin, David" sort="Belin, David" uniqKey="Belin D" first="David" last="Belin">David Belin</name>
<affiliation><nlm:affiliation>University of Bordeaux, Bordeaux Cedex, France. david.belin@inserm.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Berson, Nadege" sort="Berson, Nadege" uniqKey="Berson N" first="Nadège" last="Berson">Nadège Berson</name>
</author>
<author><name sortKey="Balado, Eric" sort="Balado, Eric" uniqKey="Balado E" first="Eric" last="Balado">Eric Balado</name>
</author>
<author><name sortKey="Piazza, Pier Vincenzo" sort="Piazza, Pier Vincenzo" uniqKey="Piazza P" first="Pier Vincenzo" last="Piazza">Pier Vincenzo Piazza</name>
</author>
<author><name sortKey="Deroche Gamonet, Veronique" sort="Deroche Gamonet, Veronique" uniqKey="Deroche Gamonet V" first="Véronique" last="Deroche-Gamonet">Véronique Deroche-Gamonet</name>
</author>
</analytic>
<series><title level="j">Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</title>
<idno type="eISSN">1740-634X</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anesthetics, Local (administration & dosage)</term>
<term>Anesthetics, Local (pharmacology)</term>
<term>Animals (MeSH)</term>
<term>Behavior, Animal (drug effects)</term>
<term>Cocaine (administration & dosage)</term>
<term>Cocaine (pharmacology)</term>
<term>Compulsive Behavior (physiopathology)</term>
<term>Compulsive Behavior (psychology)</term>
<term>Conditioning, Operant (drug effects)</term>
<term>Disease Models, Animal (MeSH)</term>
<term>Exploratory Behavior (drug effects)</term>
<term>Exploratory Behavior (physiology)</term>
<term>Male (MeSH)</term>
<term>Motor Activity (drug effects)</term>
<term>Motor Activity (physiology)</term>
<term>Rats (MeSH)</term>
<term>Rats, Sprague-Dawley (MeSH)</term>
<term>Regression Analysis (MeSH)</term>
<term>Self Administration (MeSH)</term>
<term>Statistics, Nonparametric (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anesthetics, Local</term>
<term>Cocaine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anesthetics, Local</term>
<term>Cocaine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Behavior, Animal</term>
<term>Conditioning, Operant</term>
<term>Exploratory Behavior</term>
<term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Exploratory Behavior</term>
<term>Motor Activity</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Compulsive Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Compulsive Behavior</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Male</term>
<term>Rats</term>
<term>Rats, Sprague-Dawley</term>
<term>Regression Analysis</term>
<term>Self Administration</term>
<term>Statistics, Nonparametric</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sensation/novelty-seeking is amongst the best markers of cocaine addiction in humans. However, its implication in the vulnerability to cocaine addiction is still a matter of debate, as it is unclear whether this trait precedes or follows the development of addiction. Sensation/novelty-seeking trait has been identified in rats on the basis of either novelty-induced locomotor activity (high-responder (HR) trait) or novelty-induced place preference (high-novelty-preference trait (HNP)). HR and HNP traits have been associated with differential sensitivity to psychostimulants. However, it has recently been demonstrated that HR rats do not develop compulsive cocaine self-administration (SA) after protracted exposure to the drug, thereby suggesting that at least one dimension of sensation/novelty seeking in the rat is dissociable from the vulnerability to switch from controlled to compulsive cocaine SA. We therefore investigated whether HNP, as measured as the propensity to choose a new environment in a free choice procedure, as opposed to novelty-induced locomotor activity, predicts the vulnerability to, and the severity of, addiction-like behavior for cocaine. For this, we identified HR/LR rats and HNP/LNP rats before any exposure to cocaine. After 60 days of cocaine SA, each rat was given an addiction score based on three addiction-like behaviors (persistence of responding when the drug is signaled as not available, high breakpoint under progressive ratio schedule and resistance to punishment) that resemble the clinical features of drug addiction, namely inability to refrain from drug seeking, high motivation for the drug and compulsive drug use despite adverse consequences. We show that, as opposed to HR rats, HNP rats represent a sub-population predisposed to compulsive cocaine intake, displaying higher addiction scores than LNP rats. This study thereby provides new insights into the factors predisposing to cocaine addiction, supporting the hypothesis that addiction is sustained by two vulnerable phenotypes: a 'drug use prone' phenotype such as HR which brings an individual to develop drug use and an 'addiction prone' phenotype, such as HNP, which facilitates the shift from sustained to compulsive drug intake and addiction.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20980989</PMID>
<DateCompleted><Year>2011</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1740-634X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>36</Volume>
<Issue>3</Issue>
<PubDate><Year>2011</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</Title>
<ISOAbbreviation>Neuropsychopharmacology</ISOAbbreviation>
</Journal>
<ArticleTitle>High-novelty-preference rats are predisposed to compulsive cocaine self-administration.</ArticleTitle>
<Pagination><MedlinePgn>569-79</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/npp.2010.188</ELocationID>
<Abstract><AbstractText>Sensation/novelty-seeking is amongst the best markers of cocaine addiction in humans. However, its implication in the vulnerability to cocaine addiction is still a matter of debate, as it is unclear whether this trait precedes or follows the development of addiction. Sensation/novelty-seeking trait has been identified in rats on the basis of either novelty-induced locomotor activity (high-responder (HR) trait) or novelty-induced place preference (high-novelty-preference trait (HNP)). HR and HNP traits have been associated with differential sensitivity to psychostimulants. However, it has recently been demonstrated that HR rats do not develop compulsive cocaine self-administration (SA) after protracted exposure to the drug, thereby suggesting that at least one dimension of sensation/novelty seeking in the rat is dissociable from the vulnerability to switch from controlled to compulsive cocaine SA. We therefore investigated whether HNP, as measured as the propensity to choose a new environment in a free choice procedure, as opposed to novelty-induced locomotor activity, predicts the vulnerability to, and the severity of, addiction-like behavior for cocaine. For this, we identified HR/LR rats and HNP/LNP rats before any exposure to cocaine. After 60 days of cocaine SA, each rat was given an addiction score based on three addiction-like behaviors (persistence of responding when the drug is signaled as not available, high breakpoint under progressive ratio schedule and resistance to punishment) that resemble the clinical features of drug addiction, namely inability to refrain from drug seeking, high motivation for the drug and compulsive drug use despite adverse consequences. We show that, as opposed to HR rats, HNP rats represent a sub-population predisposed to compulsive cocaine intake, displaying higher addiction scores than LNP rats. This study thereby provides new insights into the factors predisposing to cocaine addiction, supporting the hypothesis that addiction is sustained by two vulnerable phenotypes: a 'drug use prone' phenotype such as HR which brings an individual to develop drug use and an 'addiction prone' phenotype, such as HNP, which facilitates the shift from sustained to compulsive drug intake and addiction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belin</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>University of Bordeaux, Bordeaux Cedex, France. david.belin@inserm.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Berson</LastName>
<ForeName>Nadège</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Balado</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Piazza</LastName>
<ForeName>Pier Vincenzo</ForeName>
<Initials>PV</Initials>
</Author>
<Author ValidYN="Y"><LastName>Deroche-Gamonet</LastName>
<ForeName>Véronique</ForeName>
<Initials>V</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>10</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Neuropsychopharmacology</MedlineTA>
<NlmUniqueID>8904907</NlmUniqueID>
<ISSNLinking>0893-133X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>I5Y540LHVR</RegistryNumber>
<NameOfSubstance UI="D003042">Cocaine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003042" MajorTopicYN="N">Cocaine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003192" MajorTopicYN="N">Compulsive Behavior</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003216" MajorTopicYN="N">Conditioning, Operant</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005106" MajorTopicYN="N">Exploratory Behavior</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012646" MajorTopicYN="N">Self Administration</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20980989</ArticleId>
<ArticleId IdType="pii">npp2010188</ArticleId>
<ArticleId IdType="doi">10.1038/npp.2010.188</ArticleId>
<ArticleId IdType="pmc">PMC3055686</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Arch Gen Psychiatry. 2004 Mar;61(3):223-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14993109</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2004 Aug 13;305(5686):1014-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15310906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 2007 Sep;194(1):127-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17514480</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 2004 Nov;176(2):129-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15502935</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Alcohol Depend. 2003 Mar 1;69(2):121-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12609693</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2008 Jun 6;320(5881):1352-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18535246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Clin Psychopharmacol. 2005 Nov;13(4):367-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16366767</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Biochem Behav. 1989 Mar;32(3):683-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2544904</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addiction. 2010 Jun;105(6):1117-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20331554</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>NIDA Res Monogr. 1986;74:59-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3122054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Pharmacol. 2001 Jul;12(4):267-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11548112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12402102</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addict Behav. 2009 Dec;34(12):1042-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19683400</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Consult Clin Psychol. 1978 Feb;46(1):139-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">627648</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Neurosci. 2005 Nov;8(11):1450-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16251987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Brain Res. 2006 Feb 15;167(1):175-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16214235</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatry Res. 1979 Dec;1(3):255-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">298353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Biochem Behav. 1999 May;63(1):131-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10340533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2000 Sep 15;20(18):6983-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10995843</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuropeptides. 2008 Jun;42(3):245-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18410964</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Subst Abuse. 1994;6(1):1-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8081104</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Consult Clin Psychol. 2000 Oct;68(5):818-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11068968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosci Biobehav Rev. 2009 Jul;33(7):1145-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19497336</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pharmacol. 2005 Dec 5;526(1-3):36-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16289451</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Brain Res. 2011 Jan 1;216(1):159-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20655954</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers Assess. 1994 Jun;62(3):385-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8027907</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Psychiatry. 2009 May 15;65(10):863-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18639867</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1999 Jul 22;400(6742):354-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10432112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurosci. 2000 Jun 1;20(11):4226-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10818158</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Genet. 2002 Sep;32(5):349-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12405516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Encephale. 2000 Jan-Feb;26(1):68-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10875064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosci Lett. 2007 Nov 20;428(1):27-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17950531</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pers. 2000 Dec;68(6):999-1029</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11130742</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychoneuroendocrinology. 1996 Jul;21(5):441-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8888367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Pharmacol. 1990;1(4):339-345</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11175418</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Addict Behav. 1990;15(3):209-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2378281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Psychiatry. 2009 May 15;65(10):851-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19181308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Pharmacol Sci. 1998 Feb;19(2):67-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9550944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2088-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2006148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Plant Res. 2006 Jan;119(1):63-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16365787</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychoneuroendocrinology. 1982;7(2-3):217-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7178375</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 2002 Oct 4;951(2):237-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12270502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pharmacol Biochem Behav. 1990 Sep;37(1):89-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2263670</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Brain Res. 1996 May;77(1-2):23-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8762157</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1997 Oct 3;278(5335):63-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9311928</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1989 Sep 29;245(4925):1511-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2781295</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurosci Lett. 2008 Dec 3;446(2-3):105-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18824081</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Neurosci. 1998 Dec;10(12):3903-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9875367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Stud Alcohol Drugs. 2009 Nov;70(6):919-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19895768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1993 Oct 1;623(2):341-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8221119</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychopharmacology (Berl). 2004 Jan;171(3):277-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12961061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuropsychobiology. 1996;34(3):136-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8916071</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res Rev. 2008 Jun;58(1):121-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18234349</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Behav Pharmacol. 1997 Jun;8(2-3):113-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9833007</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Psychiatr Dev. 1988 Summer;6(2):83-120</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2907136</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Accid Anal Prev. 1997 Sep;29(5):651-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9316713</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuroscience. 1995 Feb;64(3):587-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7715773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Res. 1992 Jul 17;586(1):135-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1511342</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neuroscience. 2009 Mar 3;159(1):47-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19135135</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001768 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001768 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= AutomedicationFrancoV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:20980989 |texte= High-novelty-preference rats are predisposed to compulsive cocaine self-administration. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:20980989" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AutomedicationFrancoV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |